
aTyr Pharma Investor Relations Material
Latest events

Q4 2024
aTyr Pharma

Q2 2025
7 Aug, 2025

Q1 2025
6 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from aTyr Pharma Inc
Access all reports
aTyr Pharma Inc. is a biotherapeutics company focused on the discovery and development of innovative medicines based on extracellular proteins to treat rare immune, inflammatory, and fibrotic diseases. The company's research is centered around the therapeutic potential of tRNA synthetase biology. aTyr's lead clinical program targets lung diseases with unmet medical needs, particularly those related to inflammation and fibrosis. The company aims to advance novel treatments that address the underlying causes of these conditions. The company is headquartered in San Diego, California, USA, and its shares are listed on the NASDAQ.
Key slides for aTyr Pharma Inc


Corporate Presentation
aTyr Pharma Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
aTyr Pharma Inc
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
ATYR
Country
🇺🇸 United States